ReviewFrontiers in immunology2026
Beyond AQP-4: convergent glymphatic-meningeal lymphatic dysfunction underlying multifactorial migraine pathogenesis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The glymphatic system (GS) functions as a critical pathway for waste clearance from the brain, facilitating soluble protein and metabolite drainage. Recently, GS dysfunction has emerged as a potential contributor to migraine pathophysiology. GS operates similarly to the peripheral lymphatic system, dependent on astrocytes for metabolic waste removal. The clearance process involves cerebrospinal fluid entering the peri-arterial spaces, moving into the interstitial fluid via aquaporin-4 (AQP-4) channels at astrocyte feet, and eventually being drained into the cervical lymph nodes. As a downstream effector of the glymphatic system (GS), meningeal lymphatic vessels (MLVs) play a critical role in immune surveillance and regulation of cerebrospinal fluid (CSF) efflux. Calcitonin gene-related peptide (CGRP) is primarily involved in pain transmission and neuroinflammation within the nervous system. Within MLVs, CGRP modulates CSF outflow by promoting VE-cadherin rearrangement, thereby influencing pain responses in migraine mice. GS dysfunction has been observed in mice with migraine and may associate with cortical spreading depression (CSD)-induced transient perivascular space (PVS) closure. GS dysfunction has also been observed in the nitroglycerin (NTG)-induced mice migraine model. Consequently, this dysfunction might lead to the accumulation of CGRP, reactive oxygen species, and inflammatory factors, contributing to migraine initiation. In addition, CSD, a key mechanism in migraine aura, is postulated to induce transient PVS closure, disrupting GS flow. Further, impaired GS clearance would potentiate glutamatergic signaling and trigger neuroinflammation. Furthermore, AQP-4, a key component of GS, plays a crucial role in maintaining PVS function and modulating neuroinflammation. Reduced expression and impaired polarization of AQP4 may further impair GS clearance, leading to the accumulation of pathogenic mediators. GS dysfunction might be exacerbated by CSD and neuroinflammation. Further research is warranted to elucidate the underlying mechanisms and explore potential therapeutic targets aimed at restoring GS function in patients with migraine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.